Evidence map›Paper›PMID 20069295›Full record

Trial reportEuropean journal of nuclear medicine and molecular imaging2010

Biodistribution and radiation dosimetry of [(11)C]choline: a comparison between rat and human data.

Tuula Tolvanen, Timo Yli-Kerttula, Tiina Ujula, Anu Autio, Pertti Lehikoinen, Heikki Minn, Anne Roivainen

Registry-linked trialAbstract readClinical TrialComparative Study
PubMed Publisher
In one paragraph

Trial report in European journal of nuclear medicine and molecular imaging, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01377220 (Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01377220 phase2unknown statusnot on this mapstarted 2011, after this paper: background citation

Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma

TypeinterventionalSponsorCommissariat A L'energie AtomiqueRan2011 to 2014Enrolled30ConditionsHepatocellular CarcinomaArms11C-Choline
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 74 citations in OpenAlex.

  1. Trial
  2. Prospective head-to-head comparison ofEuropean journal of nuclear medicine and molecular imaging · 2017
    Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. The EANM practice guidelines for parathyroid imaging.European journal of nuclear medicine and molecular imaging · 2021
    Article
  8. Article
  9. Radiation dosimetry ofEJNMMI research · 2020
    Article
  10. Article
  11. Article
  12. Preclinical Evaluation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Tuula TolvanenTurku PET Centre, Turku University Hospital, FI-20521, Turku, Finland.
Timo Yli-Kerttula
Tiina Ujula
Anu Autio
Pertti Lehikoinen
Heikki Minn
Anne Roivainen
Turku University Hospital · FITurku PET Centre · FIUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMethyl-(11)C-choline ([(11)C]choline) is a radiopharmaceutical used for oncological PET studies. We investigated the biodistribution and biokinetics of [(11)C]choline and provide estimates of radiation doses in humans.

methodsThe distribution of [(11)C]choline was evaluated ex vivo in healthy rats (n=9) by measuring the radioactivity of excised organs, and in vivo in tumour-bearing rats (n=4) by PET. In addition to estimates of human radiation doses extrapolated from rat data, more accurate human radiation doses were calculated on the basis of PET imaging of patients with rheumatoid arthritis (n=6) primarily participating in a synovitis imaging project with [(11)C]choline. Dynamic data were acquired from the thorax and abdomen after injection of 423+/-11 MBq (mean+/-SD) of tracer. Following PET imaging, the radioactivity in voided urine was measured. The experimental human data were used for residence time estimations. Radiation doses were calculated with OLINDA/EXM.

resultsIn rats, the radioactivity distributed mainly to the kidneys, lungs, liver and adrenal gland. The effective dose in a human adult of about 70 kg was 0.0044 mSv/MBq, which is equivalent to 2.0 mSv from 460 MBq of [(11)C]choline PET. The highest absorbed doses in humans were 0.021 mGy/MBq in the kidneys, 0.020 mGy/MBq in the liver and 0.029 mGy/MBq in the pancreas. Only 2.0% of injected radioactivity was excreted in the urine during the 1.5 h after injection.

conclusionThe absorbed radiation doses after administration of 460 MBq of [(11)C]choline were low. Except for the pancreas, biodistribution in the rat was in accordance with that in humans, but rat data may underestimate the effective dose, suggesting that clinical measurements are needed for a more detailed estimation. The observed effective doses suggest the feasibility of [(11)C]choline PET for human studies.

Indexed as

AdultAnimalsCholineFemaleHumansMaleMiddle AgedPositron-Emission TomographyRadiation DosageRadiometryRadiopharmaceuticalsRatsCholinemethyl carbon-11 cholineRadiopharmaceuticals

Identifiers

PMID20069295
OpenAlexW2083197755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.